Evidence map›Paper›PMID 41217653›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2025

Application of Supplements Based on Soybean By-products Containing Lacticaseibacillus casei (ATCC®393

Adriana P Castellanos-Fuentes, Silvia K Flores, Marina F de Escalada Pla

Abstract read
PubMed Publisher
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adriana P Castellanos-FuentesUniversidad de Buenos Aires (UBA), Facultad de Ciencias Exactas y Naturales (FCEN), Departamento de Industrias. Intendente Güiraldes, Buenos Aires, 2160, Argentina.
Silvia K FloresUniversidad de Buenos Aires (UBA), Facultad de Ciencias Exactas y Naturales (FCEN), Departamento de Industrias. Intendente Güiraldes, Buenos Aires, 2160, Argentina.
Marina F de Escalada PlaUniversidad de Buenos Aires (UBA), Facultad de Ciencias Exactas y Naturales (FCEN), Departamento de Industrias. Intendente Güiraldes, Buenos Aires, 2160, Argentina. marina@di.fcen.uba.ar.ORCID http://orcid.org/0000-0003-4204-8128

Funding

Universidad de Buenos Aires UBACyT 20020220200171BA
6 · The paper itself

Abstract

The aim of the present work was to apply functional ingredients (FIs) prepared with soybean by-products (okara or expeller) containing L. casei (ATCC 393), as supplements in smoothies based on orange juice or reduced-lactose milk. The processing applied to obtain the FIs increased the dispersion of particles sizes. In general, okara ingredients (OI) presented less solid behaviour, denser powders with higher compressibility than expeller ingredients (EI). Regarding banana smoothies based on orange or milk, the formulations presented a pseudoplastic behaviour, with the orange juice smoothie supplemented with OI showing the highest consistency. In addition, 66-96% of probiotic cells supported in the FIs remained metabolically active when they reached the large intestine. Orange-based smoothies presented the best score on the hedonic scale in a sensory test. Soybean based FIs containing probiotics demonstrated to be a good alternative for supplementing fruit smoothies, enhancing both consumer acceptance and potential health benefits.

Indexed as

Dietary SupplementsFruitGlycine maxLacticaseibacillus caseiProbioticsAnimalsCitrus sinensisFruit and Vegetable JuicesHumansMusaParticle SizePlant ProteinsPolysaccharidesSoy Foodsokara, Glycine maxPlant ProteinsPolysaccharidesFruit-smoothiesGastrointestinal resistanceLacticaseibacillus caseiOkaraSoybean extruded-expelled meal

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.